Iron Med RX review

What it is

Iron Med RX is an online prescribing platform trading as IRON Peptides, reachable at ironmedrx.com, which redirects to home.ironmedrx.com. Its published address is 131 Continental Dr. Ste 305, Newark, Delaware, with a support email and phone number. Care is described as delivered entirely online — "We provide medical care online — simple, direct, and led by licensed providers" — with prescribing through the OpenLoop Health clinician network and dispensing by state-licensed pharmacies. Its categories are weight loss, peptides and longevity, men's health, women's health and skincare, and the longevity line names injectable NAD⁺, CJC-1295/ipamorelin and BPC-157. Its GLP-1 side carries compounded semaglutide and tirzepatide in both oral tablet and injectable form, plus microdosing.

How it works

Fully virtual: you create an account, complete an intake, a licensed provider reviews it and builds a plan, and anything prescribed ships to your door with virtual follow-ups. Two disclosures here are better than our earlier record showed. The prescribing network is now named as OpenLoop Health, which tells you which organisation employs the clinician making the decision — that is a real, checkable fact rather than a claim about unnamed "licensed providers". And the operating address has moved to Newark, Delaware from the Dallas private mailbox previously on file. What has not improved is anything you would need to compare it against a competitor. No state list is published, so you cannot confirm eligibility before creating an account. No compounding pharmacy is named. There is no lab work described in the default path, which is worth pausing on given that CJC-1295 and ipamorelin act on the growth-hormone axis and an IGF-1 baseline is the obvious thing to want before starting one. And no third-party accreditation is displayed.

Pricing transparency

Advertised and absent at the same time, which is the single most frustrating thing about this listing. The site markets "clear pricing" as a feature and publishes no price for any product, peptide or otherwise; its storefront reveals figures only after you create an account. So we are not quoting a number for CJC-1295/ipamorelin, BPC-157 or NAD⁺, because there is not one to quote and substituting a GLP-1 figure would misdescribe what you are buying. Account-gated pricing is worth naming as a pattern rather than an inconvenience: it prevents comparison shopping by design, and it means the first real number you see arrives at a point where you have already invested time and handed over personal health information. Before creating an account, ask by email what each named peptide costs per month, what dose and quantity that supplies, whether the price changes as the dose escalates, whether there is a separate membership or consultation fee, and what the cancellation terms are.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Medication is described as dispensed by state-licensed pharmacies, but no pharmacy is named and no 503A or 503B designation is given, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. The value of naming molecules is that they can be graded, and these three do not sit at the same level. CJC-1295 and ipamorelin act on the growth-hormone axis — a genuine, well-described mechanism — but the long-term human outcome data stays thin, and no controlled trial demonstrates the body-composition, recovery or anti-aging results the pairing is marketed for. BPC-157 sits lower: essentially no controlled human outcome trials support the tissue-repair and recovery claims attached to it, which are inherited from animal studies and user reports, and its availability through compounding pharmacies has moved with FDA decisions on the bulk substance, so confirm what can actually be dispensed to you today. Injected NAD⁺ has no controlled outcome trials either; the oral precursors NR and NMN are the forms with human data, and they raise blood NAD⁺ rather than demonstrating a clinical benefit. One further flag from the GLP-1 side that bears on how the catalogue is written: the platform has marketed its oral semaglutide as a "research-grade formulation", and "research grade" is language normally attached to material not intended for human use. Confirm in writing that anything you are prescribed is being dispensed for human use. Individual results vary.

Pros and watch-outs

The evidence behind what Iron Med RX prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• BPC 157: what the evidence actually shows (and what it doesn't)

  The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Iron Med RX compares

A few alternatives worth a look, depending on what you’re optimizing for.

• DRDrBrainRx

  NAD⁺ from a LegitScript-certified clinic with a named specialist founder

  See DrBrainRx →
• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• LHLuvo Health

  Prescription NAD⁺ as an injection, drops or nasal spray at one flat price

  See Luvo Health →